(Q36729827)

15 August 2017

1 reference

title

Cognitive functions in primary central nervous system lymphoma: literature review and assessment guidelines (English)

1 reference

central nervous system lymphoma

15 August 2017

1 reference

1 reference

based on heuristic

inferred from title

primary central nervous system lymphoma

1 reference

0 references

D D Correa

1

1 reference

15 August 2017

L Maron

2

1 reference

15 August 2017

H Harder

3

1 reference

15 August 2017

M Klein

4

1 reference

15 August 2017

C L Armstrong

5

1 reference

15 August 2017

P Calabrese

6

1 reference

15 August 2017

J E C Bromberg

7

1 reference

15 August 2017

L E Abrey

8

1 reference

15 August 2017

T T Batchelor

9

1 reference

15 August 2017

D Schiff

10

1 reference

15 August 2017

6 February 2007

1 reference

15 August 2017

1 reference

15 August 2017

18

1 reference

15 August 2017

7

1 reference

15 August 2017

1145-1151

1 reference

High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.

15 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

Cognitive functions in survivors of primary central nervous system lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

Cognitive status and quality of life after treatment for primary CNS lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

Primary central nervous system lymphoma: age and performance status are more important than treatment modality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

Cognitive functioning and quality of life in malignant glioma patients: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

Neurological complications of radiotherapy and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

Cognitive sequelae of brain radiation in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

Concomitant loss of dynorphin, NARP, and orexin in narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred Radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

Cognitive functioning in long-term survivors of high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

Multiple brain metastases: a rare manifestation of adenoid cystic carcinoma of the parotid gland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

A critical review of the clinical effects of therapeutic irradiation damage to the brain: the roots of controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

Insulin analogues - state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

Practice effects during repeated administrations of memory tests with and without alternate forms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL464

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDL464

1 reference

15 August 2017

1 reference